According to the monthly filing for the period ended 31 July 2025, Boill Healthcare Holdings Limited (stock code: 01246) reported that its authorized share capital remained at 480,000,000 ordinary shares at a par value of HKD 0.25, with a total of HKD 120,000,000. No increase or decrease was recorded during July 2025.

The company’s issued shares totaled 1,358,000,000, with no change from the preceding month. Public float requirements were met with a minimum of 25% of the issued shares held by the public. Additionally, there were no shares issued or repurchased, and no new funds were raised.

The share option scheme adopted on 27 September 2023 remains in place, with a maximum of 135,800,000 shares that may be issued under the scheme. No share options were exercised, and no new options were granted during the reporting period.